Found 4 matching trials
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer PHASE2 This study will monitor the safety of novel immunotherapy combinations in p...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial
A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202 PHASE2 The primary purpose of the study is to evaluate the antitumor activity and ...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial
Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3 PHASE2 This study is a sub-study of the master protocol 205801 (NCT03739710). This...
Show More Location
GSK Investigational SIte
Learn More & Join Trial
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors PHASE1 This is a first time in-human (FTIH) study designed to investigate the safe...
Show More Status
Active Not Recruiting
Location
GSK Investigational Site
Learn More & Join Trial